References
- Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8(4):222–6.
- Chatterjee S, Bhattacharya M, Todi SK. Epidemiology of Adult-population Sepsis in India: A Single Center 5 Year Experience. Indian J Crit Care Med. 2017;21(9):573–7.
- Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.
- Gaddam BK, Narayanan M. Study of serum HDL-cholesterol levels in sepsis patients and its prognostic significance. Int J Adv Med. 2019;6(2):312–17.
- Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly. 2005;135(31–32):451–60.
- Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol. 2020; 11:599853.
- van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31(5):1359–66.
- Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase is increased in vivo by inflammation in humans. Circulation. 2008;117(5):678–85.
- Tanaka S, Couret D, Tran-Dinh A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134.
- Rapsang AG, Shyam DC. Scoring systems in the intensive care unit: A compendium. Indian J Crit Care Med. 2014;18(4):220–8.
- Badrinath K, Shekhar M, Sreelakshmi M, et al. Comparison of Various Severity Assessment Scoring Systems in Patients with Sepsis in a Tertiary Care Teaching Hospital. Indian J Crit Care Med. 2018;22(12):842–845.
- APACHE II – ClinCalc. http:// ClinCalc.com>ICU Mortality>APACHE II.
- Rudd KE, Johnson SC, Agesa KM, et al. D. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200–11.
- Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ 2016;353: i1585.
https://www.who.int/news-room/fact-sheets/detail/sepsis .- Napolitano LM. Sepsis 2018: Definitions and Guideline Changes. Surg Infect (Larchmt). 2018;19(2):117–25.
- Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017; 5:51.
- Dahaba AA, Hagara B, Fall A, et al. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006;97(4):503–8.
- Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect. 2002;8(2):93–100.
- Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018;13(11): e0206527.
- Rashwan D, Al Kassem Rashwan SA, Hassan WF, Sayem DM. Prognostic Value of Serum Cholesterol and Triglyceride in Septic and Non-septic Patients: Randomized Double-blinded Study. J Intensive & Crit Care. 2019;1:1–7.
- Sunayana P, Renymol B, Ambili N. Fasting Lipid Profile and Disease Severity in Sepsis Patients. Journal of Clinical and Diagnostic Research. 2017;11(11): OC10–OC12.
- Cetinkaya A, Erden A, Avci D, et al. Is hypertriglyceridemia a prognostic factor in sepsis? Ther Clin Risk Manag. 2014; 10:147–50.
- Sharma NK, Ferreira BL, Tashima AK, et al. Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis. Clin Proteomics. 2019; 16:29.
- Morin EE, Guo L, Schwendeman A, Li XA. HDL in sepsis - risk factor and therapeutic approach. Front Pharmacol. 2015;6:244.
- Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688–93.
- Maile MD, Sigakis MJ, Stringer KA, Jewell ES, Engoren MC. Impact of the pre-illness lipid profile on sepsis mortality. J Crit Care. 2020;57:197–202.
- Chang L, Chen X, Lian C. The association between the non-HDL-cholesterol to HDL-cholesterol ratio and 28-day mortality in sepsis patients: a cohort study. Sci Rep. 2022;12(1):3476.